Honasa Consumer Ltd vs Samsrita Labs Ltd Stock Comparison
Honasa Consumer Ltd vs Samsrita Labs Ltd Stock Comparison
Last Updated on: Oct 25, 2026
Key Highlights
The Latest Trading Price of Honasa Consumer Ltd is ₹ 431.4 as of 23 Oct 15:30
. The P/E Ratio of Honasa Consumer Ltd changed from 116.5 on March 2024 to 48.5 on March 2026 . This represents a CAGR of -25.33% over 3 yearsThe P/E Ratio of Samsrita Labs Ltd changed from 28.5 on March 2022 to 0 on March 2026 . This represents a CAGR of -100.00% over 5 years The Market Cap of Honasa Consumer Ltd changed from ₹ 13034 crore on March 2024 to ₹ 9700 crore on March 2026 . This represents a CAGR of -9.38% over 3 yearsThe Market Cap of Samsrita Labs Ltd changed from ₹ 64.64 crore on March 2021 to ₹ 36.08 crore on March 2026 . This represents a CAGR of -9.26% over 6 years The revenue of Honasa Consumer Ltd for the Jun '26 is ₹ 778.51 crore as compare to the Mar '26 revenue of ₹ 675.96 crore. This represent the growth of 15.17% The revenue of Samsrita Labs Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 revenue of ₹ 0.05 crore. This represent the decline of -100% The ebitda of Honasa Consumer Ltd for the Jun '26 is ₹ 132.76 crore as compare to the Mar '26 ebitda of ₹ 95.97 crore. This represent the growth of 38.33% The ebitda of Samsrita Labs Ltd for the Jun '26 is ₹ -0.31 crore as compare to the Mar '26 ebitda of ₹ -0.12 crore. This represent the growth of 158.33% The net profit of Honasa Consumer Ltd changed from ₹ 26.02 crore to ₹ 90.45 crore over 9 quarters. This represents a CAGR of 73.98%
The net profit of Samsrita Labs Ltd changed from ₹ -0.28 crore to ₹ -0.31 crore over 5 quarters. This represents a CAGR of 8.48%
The Dividend Payout of Honasa Consumer Ltd changed from 51.15 % on March 2026 to 51.15 % on March 2026 . This represents a CAGR of 0.00% over 1 yearsThe Dividend Payout of Samsrita Labs Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .
About Honasa Consumer Ltd
Honasa Consumer Limited was incorporated as Honasa Consumer Private Limited' at New Delhi as a Private Limited company on September 16, 2016.
Subsequently, Company converted to a Public Limited, reflecting the change in name of the Company to Honasa Consumer Limited' dated November 11, 2022 by the RoC.
The Company is the largest digital-first BPC company in India in terms of revenue from operations.
It has built a House of Brands' architecture with a portfolio of six brands in the BPC space.
Dating back to their journey, Mamaearth has helped the Company in scaling their newer brands at a fast pace.
These playbooks are powered by consumer-centric approach across various business model, including innovation engine, digitalized omni-channel distribution, technology and data-driven marketing and consumer engagement model.
About Samsrita Labs Ltd
Samsrita Labs Limited was initially established as 'Dr Habeebullah Life Sciences Limited' on January 25, 1996.
The name of the Company was changed from Dr Habeebullah Life Sciences Limited to Samsrita Labs Limited on October 13, 2022.
Company, initially focused on three different verticals called, Stem cell related Hospitals, Molecular Diagnostics and R&D in New Drug Discovery but due to other reasons, aimed to shifting into Bio-pharma activities like Trading, Exports & Imports, manufacturing of Bulk drugs, APIs, Specialty drugs, R&D etc through joint ventures or associations or mergers or by its own.
The Company is engaged into the business of research & experimental development on natural sciences and engineering, including bio pharma and hospital services also.
In 2017, the Company changed its Main Objects clauses by venturing into the business of Bio-Pharma and also entered the following areas like New Drug Discovery including New Molecular Entity (NME - Pro Drug); Clinical Research Organization (CRO) related activities; Stem Cell - Lab, Research and Therapy; Research and Development in Bio-technology; Consultancy Division and Pharmacy; Academic Services like Courses / Lectures / Seminars on Biotechnology, Pharma, Stem Cell Research and therapy, Clinical Research and animal studies etc.
FAQs for the comparison of Honasa Consumer Ltd and Samsrita Labs Ltd
Which company has a larger market capitalization, Honasa Consumer Ltd or Samsrita Labs Ltd?
Market cap of Honasa Consumer Ltd is 14,064 Cr while Market cap of Samsrita Labs Ltd is 30 Cr
What are the key factors driving the stock performance of Honasa Consumer Ltd and Samsrita Labs Ltd?
The stock performance of Honasa Consumer Ltd and Samsrita Labs Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.
What are the recent stock price for Honasa Consumer Ltd and Samsrita Labs Ltd?
As of October 25, 2026, the Honasa Consumer Ltd stock price is INR ₹431.4. On the other hand, Samsrita Labs Ltd stock price is INR ₹13.42.
How do dividend payouts of Honasa Consumer Ltd and Samsrita Labs Ltd compare?
To compare the dividend payouts of Honasa Consumer Ltd and Samsrita Labs Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.